Abstract

The significant global burden of periodontitis has increased over the past few decades. However, the regeneration and reconstruction of periodontal tissue remain major challenges in clinical practice. Successful periodontal treatment relies on the regulation of calcium signaling. Bone mesenchymal stem cell-derived exosomes (BMSC Exo) hold great potential for promoting calcium influx to enhance osteogenic differentiation, modulate the inflammatory microenvironment, and promote angiogenesis, but their therapeutic efficiency is limited by inadequate stability. To overcome this problem, a mild and facile approach using protocatechualdehyde was employed to modify BMSC Exo (PA@BMSC Exo) through covalent and noncovalent polyphenolic interactions. The resulting PA@BMSC Exo system enhanced the stability against external stress and augmented its ability to induce intracellular calcium entry. Osteogenesis in human periodontal ligament stem cells (hPDLSCs) and integrated periodontal regeneration in periodontitis were observed following PA@BMSC Exo treatment. Furthermore, these multifunctional PA@BMSC Exo also promoted immunoinflammatory regulation and neovascularization. Bioinformatic analysis based on RNA sequencing (RNA-seq) predicted that the osteogenic differentiation of hPDLSCs was enhanced by calcium influx mediated through the voltage-gated calcium channel Ca v 3.3. Intracellular Ca 2+ levels were further validated in hPDLSCs, as well as in RAW264.7 cells and human umbilical vein endothelial cells (HUVECs). Overall, a facile engineered PA@BMSC Exo system was successfully developed to reverse periodontal destruction by orchestrating calcium signaling and the entire periodontal microenvironment, potentially opening a new avenue for the clinical treatment of chronic periodontitis.